药物诱导的表观遗传变化:一组法医毒理学指纹? - - 一个系统性审查
Simone Grassi1,2, Andrea Costantino2, Alexandra Dimitrova1
1FT-LAB Forensic Toxicology Laboratory, Department of Health Science, University of Florence, 50121 Florence, Italy.
Genes
|October 29, 2025
概括
精神活性物质的使用会导致特定的表观遗传变化,如DNA甲基化变化,这可能作为毒理指纹. 然而,法医使用目前受到混因素的限制,需要进一步的标准化研究来验证.
科学领域:
- 表观遗传学和分子毒理学
- 法医科学和生物标志物
背景情况:
- 表观遗传学涉及遗传的基因表达变化,而不会改变DNA序列.
- 环境因素,包括精神活性物质,影响表观遗传机制,如DNA甲基化,基因质修饰和非编码RNA.
- 药物诱导的表观遗传变化被假设为具有法医相关性的潜在分子标记.
研究的目的:
- 系统地审查药物诱导人类表观遗传变化的证据.
- 评估这些表观遗传修饰的潜力,作为用于法医应用的毒理指纹.
主要方法:
- 按照PRISMA指南进行系统的文献搜索 (PubMed,2010-2025).
- 包括以英语出版的人体样本研究.
- 排除动物研究和缺乏表观遗传数据的动物研究.
主要成果:
- 42项研究证实,常见的物质 (酒精,可卡因,甲基胺,大麻,阿片类药物) 诱导特定的表观遗传变化.
- 观察到的修改包括改变的CpG甲基化,miRNA表达变异和调制的表观遗传酶.
- 这些持续变化在脑组织,血细胞和精液中被检测到,即使在药物停止后也是如此.
结论:
- 精神活性物质的使用被证明与特定的表观遗传修饰有关.
- 法医应用目前受到混变量 (年龄,共同暴露,死后间隔) 的限制.
- 标准化研究对于验证表观遗传变化作为可靠的法医生物标志物至关重要.
关键词:
通过DNA甲基化.生物标志物 生物标志物滥用药物 滥用药物 滥用药物 滥用药物 滥用药物表观遗传学是指表观遗传学.法医毒理学 法医毒理学基斯顿基因基因基因基因基因基因基因基因基因基因基因基因基因基因这是一个小RNARNA.精神活性物质是一种精神活性物质.更多相关视频
12:15Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
Published on: May 29, 2019
9.1K
11:49Enhanced Genetic Analysis of Single Human Bioparticles Recovered by Simplified Micromanipulation from Forensic ‘Touch DNA’ Evidence
Published on: March 9, 2015
16.6K
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
